USITC to Investigate Infusion Therapy Product Trade Violations

The U.S. International Trade Commission (USITC) says it will   investigate patent infringement/trade violations for certain intravascular administration sets and components, based on a March 13 complaint.

The complaint, against Yangzhou WeiDeLi Trade, of Yangzhou, China, was filed by Curlin Medical, and Moog, both of East Aurora, NY, and Zevex, of Salt Lake City, UT. 

The devices are infusion therapy products, such as infusion pumps and disposable tubing used to deliver nutrients or medication into a patient’s body.

The complaint alleges violations of section 337 of the Tariff Act of 1930 on the importation into the U.S., of products that allegedly infringe complainants’ patents. Complainants requested that USITC issue a limited exclusion order and a cease and desist order.